Sumitomo Mitsui Trust Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.8M Buy
666,581
+33,124
+5% +$1.88M 0.03% 482
2026
Q1
$40.7M Buy
633,457
+251,732
+66% +$23M 0.03% 497
2025
Q4
$49.6M Buy
381,725
+89,470
+31% +$12.3M 0.03% 465
2025
Q3
$31.5M Buy
+292,255
New +$31.8M 0.02% 582

Other funds holding WGS

Sumitomo Mitsui Trust Group's WGS Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group increased its GeneDx Holdings (WGS) stake by 5.2% in Q2 2026, buying an estimated $1.88M and bringing the position to 666,581 shares worth $45.8M. The position accounts for 0.03% of the portfolio, ranked #482.

Sumitomo Mitsui Trust Group first reported a position in WGS in Q3 2025 and has held it in 4 quarters since. The position peaked at $49.6M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 666,581 shares of GeneDx Holdings worth $45.8M as of Q2 2026.
  • Sumitomo Mitsui Trust Group bought 33,124 GeneDx Holdings shares in Q2 2026, an estimated $1.88M.
  • GeneDx Holdings made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #482 holding.
  • Sumitomo Mitsui Trust Group first reported a position in GeneDx Holdings in Q3 2025 and has held it in 4 quarters since.
  • Sumitomo Mitsui Trust Group's GeneDx Holdings position peaked at $49.6M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.